Network Pharmacology Study of Antibacterial and Antiviral Active Components of JibeiKechuan Capsule in Treatment of A-ECOPD

Qian Zeng,Xiangpei Wang,Feng Xu,Fengyun Jin,Hongmei Wu
2021-01-01
Abstract:Objective: To analyze the mechanism of antibacterial and antiviral effects of effective components of JibeiKechuan Capsule in the treatment of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) based on network pharmacology. Methods: The main components and target information of 11 traditional Chinese medicines in JibeiKechuan capsule were collected and selected by CNKI, TCMSP, SwissTargetPrediction and Huayuan.com databases. Cytoscape3.8.0 software was used to construct a drug-component-target network. GeneCards database was used to collect antibacterial and antiviral target information. The Venny online platform was used to analyze common intersection targets and draw A Venn diagram. Protein interaction analysis was conducted through STRING platform to build PPI network. GO analysis and KEGG signal pathway enrichment analysis were performed by David database (P < 0.05). Results: A total of 161 main components, 883 targets, 6465 antibacterial and antiviral related targets and 537 common intersection targets of JibeiKechuan capsule were screened. 34 potential targets were screened, including ATK1, MAPK3, RELA, NF-κB1, PAK3CA, MAPK1, MAPK14, MAPK8 and TNF. 358 GO biological processes and 103 KEGG signal enrichment pathways were obtained, mainly involving PI3K/Akt signaling pathway, MAPK signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, etc. Conclusion: The results of this study indicate that JibeiKecchuan capsule may be involved in PI3K/Akt signaling pathway, MAPK signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway and TNF signaling pathway by acting on ATK1, MAPK3, RELA, NF-κB1, PAK3CA, TNF and other key targets through the active ingredients of various medicinal materials. The effect of virus fully reflects the antibacterial and antiviral mechanism of JibeiKechuan capsule in the treatment of AECOPD with multiple components, multiple targets and multiple pathways, providing theoretical reference for further elucidating the mechanism of Action of JibeiKechuan capsule.
What problem does this paper attempt to address?